 | Dr. Lori J. Wirth is an Instructor of Medicine with the Head and Neck Oncology Program at the Dana-Farber Cancer Institute, one of the first multi-disciplinary head and neck cancer programs established in this country. Dr. Wirth graduated in 1987 from Brown University and received her MD from Columbia University College of Physicians and Surgeons in New York in 1997. She completed a residency in Internal Medicine at at New York Presbyterian Hospital in 2000 and became a fellow in Medical Oncology at the Dana-Farber Cancer Institute. She completed her fellowship in 2003 and became an Instructor. |
The Head and Neck Oncology Program is one component of the Harvard Head and Neck Oncology Program, a Harvard-wide effort in head and neck cancer, and provides the clinical and research center for the treatment and study of head and neck cancer at the Dana-Farber Cancer Institute, The Harvard Medical School, the Brigham and Women’s Hospital, The Beth-Israel Deaconess Medical Center, and the Harvard School of Dental Medicine.
The Head and Neck Oncology Program provides excellent multi-disciplinary care for the patients as its first order of business, and coordinates an extensive clinical and laboratory based research effort. Over 500 new cases of head and neck cancer are seen each year and more then 100 patients participate in active clinical trials and many more contribute blood and tissue samples for the molecular epidemiology program and tissue bank.